Thunder God Vine Extract Could Treat Pancreatic Cancer

Triptolide, an extract of the thunder god vine used in Chinese medicine, has been shown to kill pancreatic cancer cells.

AsianScientist (Jul 11, 2014) – Researchers have found that an extract of the Chinese herb thunder god vine (Tirpterygium wilforii), could be used to treat pancreatic cancer. The results of this study have been published in the American Journal of Physiology – Gastrointestinal and Liver Physiology.

A diagnosis of pancreatic cancer—the fourth most common cause of cancer death in the U.S.—can be devastating. Due in part to aggressive cell replication and tumor growth, pancreatic cancer progresses quickly and has a low five-year survival rate (less than five percent).

GRP78, a protein that protects cells from dying, is more abundant in cancer cells and tissue than in normal organs and is thought to play a role in helping pancreatic cancer cells survive and thrive.

For mammals to use the proteins in our bodies, a process called protein folding must occur in the endoplasmic reticulum (ER) of cells. If proteins are not folded properly, unfolded proteins begin to build up and the cell becomes stressed. Prolonged ER stress activates a cellular process called the unfolded protein response (UPR). Initially, the UPR helps kick-start the cell’s protein-folding ability, allowing it to function properly again. But if the problem doesn’t resolve, the UPR triggers cell death.

GRP78 helps cells survive long enough for the UPR to kick in and correct protein-folding problems. However, GRP78 is available in higher quantities in pancreatic cancer cells, which assists the cancer cells in evading cell death, allowing them to live and multiply.

Triptolide, an extract of the thunder god vine used in Chinese medicine, has previously been shown to have a negative effect on pancreatic cancer cell viability and to block growth and spread of these cells. In this study led by Dr. Ashok Saluja, researchers observed the effects of triptolide on human pancreatic cancer cells and tissue. They found that the UPR worked properly in triptolide-treated cells to allow cell death in malfunctioning cells.

“Our study shows that although increased expression of GRP78 confers a survival advantage to the tumor cells, prolonged exposure to triptolide induces chronic ER stress, which eventually leads to cell death,” the authors stated. “In this context, inhibition of GRP78 by activation of the ER stress pathway by triptolide offers a novel mechanism for inhibiting the growth and survival of pancreatic cancer cells.”

The article can be found at: Mujumdar et al. (2014) Triptolide Activates Unfolded Protein Response Leading to Chronic ER Stress in Pancreatic Cancer Cells.

——–

Source: American Physiological Society; Photo: watashiwani/Flickr/CC.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.

Asian Scientist Magazine is an award-winning science and technology magazine that highlights R&D news stories from Asia to a global audience. The magazine is published by Singapore-headquartered Wildtype Media Group.

Related Stories from Asian Scientist